MedTrace Logo

Neuromuscular Electrostimulation in Radiocephalic Fistula

NCT02925845 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2016-10-06

No results posted yet for this study

Summary

* Objective: To analyze the effect of neuromuscular electrostimulation in the maturation of radiocephalic arteriovenous fistula (RC-AVF) patients with chronic kidney disease (CKD) stage 5-5D
* Design: Clinical Trial with medical devices, 18-month, single-center, within the hospital setting.
* Disease or disorder study: vascular Access maturation.
* Population: Patients with CKD stage 5-5D at the research center.
* Project duration: 78 weeks
* Methodology:
* Patients with CKD stages 5-5D that has undergone a native AV in service stations to give their informed consent and meeting the inclusion criteria will be included.
* At baseline two study groups were established:

* Group 1: neuromuscular electrostimulation
* Group 2: isometric exercises

Conditions

  • Arteriovenous Fistula

Interventions

DEVICE

Neuromuscular electrostimulation

The device CompexTheta 400i provided with various developmental programs rehabilitation exercise with different phases, types and current is used. an adaptive program (heating, toning, muscular atrophy, strength-endurance) will be established for each patient during the study period. It shall apply at the level of the muscle bellies of the flexor and extensor muscles of the forearm dela upper extremity AV created. Electrodes are positioned at the anatomical reference positions. The intensity of the current will increase until a tolerable muscle contraction and painless by the patient.

Sponsors & Collaborators

  • Hospital de Terrassa

    lead OTHER

Principal Investigators

  • Lucía Inés Martínez Carnovale, MD · Hospital de Terrassa CST

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-11-30
Completion
2017-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02925845 on ClinicalTrials.gov